These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22247456)

  • 1. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration.
    Martínez-Barricarte R; Recalde S; Fernández-Robredo P; Millán I; Olavarrieta L; Viñuela A; Pérez-Pérez J; García-Layana A; Rodríguez de Córdoba S;
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1087-94. PubMed ID: 22247456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
    Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
    Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population.
    Liu X; Zhao P; Tang S; Lu F; Hu J; Lei C; Yang X; Lin Y; Ma S; Yang J; Zhang D; Shi Y; Li T; Chen Y; Fan Y; Yang Z
    Retina; 2010 Sep; 30(8):1177-84. PubMed ID: 20523265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.
    Ansari M; McKeigue PM; Skerka C; Hayward C; Rudan I; Vitart V; Polasek O; Armbrecht AM; Yates JR; Vatavuk Z; Bencic G; Kolcic I; Oostra BA; Van Duijn CM; Campbell S; Stanton CM; Huffman J; Shu X; Khan JC; Shahid H; Harding SP; Bishop PN; Deary IJ; Moore AT; Dhillon B; Rudan P; Zipfel PF; Sim RB; Hastie ND; Campbell H; Wright AF
    Hum Mol Genet; 2013 Dec; 22(23):4857-69. PubMed ID: 23873044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number variation in the complement factor H-related genes and age-related macular degeneration.
    Kubista KE; Tosakulwong N; Wu Y; Ryu E; Roeder JL; Hecker LA; Baratz KH; Brown WL; Edwards AO
    Mol Vis; 2011; 17():2080-92. PubMed ID: 21850184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration.
    Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
    Hum Mol Genet; 2008 Apr; 17(7):971-7. PubMed ID: 18084039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration.
    Schmid-Kubista KE; Tosakulwong N; Wu Y; Ryu E; Hecker LA; Baratz KH; Brown WL; Edwards AO
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5070-9. PubMed ID: 19553609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans.
    Contreras AV; Zenteno JC; Fernández-López JC; Rodríguez-Corona U; Falfán-Valencia R; Sebastian L; Morales F; Ochoa-Contreras D; Carnevale A; Silva-Zolezzi I
    Mol Vis; 2014; 20():105-16. PubMed ID: 24453474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.
    Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M;
    Ann Med; 2006; 38(8):592-604. PubMed ID: 17438673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
    Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
    JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.
    Buentello-Volante B; Rodriguez-Ruiz G; Miranda-Duarte A; Pompa-Mera EN; Graue-Wiechers F; Bekker-Méndez C; Ayala-Ramirez R; Quezada C; Rodríguez-Loaiza JL; Zenteno JC
    Mol Vis; 2012; 18():2518-25. PubMed ID: 23112567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.
    Lima LH; Schubert C; Ferrara DC; Merriam JE; Imamura Y; Freund KB; Spaide RF; Yannuzzi LA; Allikmets R
    Ophthalmology; 2010 Aug; 117(8):1567-70. PubMed ID: 20378180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent.
    Raychaudhuri S; Ripke S; Li M; Neale BM; Fagerness J; Reynolds R; Sobrin L; Swaroop A; Abecasis G; Seddon JM; Daly MJ
    Nat Genet; 2010 Jul; 42(7):553-5; author reply 555-6. PubMed ID: 20581873
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population.
    Chu J; Zhou CC; Lu N; Zhang X; Dong FT
    Chin Med J (Engl); 2008 Dec; 121(24):2525-33. PubMed ID: 19187590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic variants rs641153 (
    Neto JM; Viturino MG; Ananina G; Bajano FF; Costa SMDS; Roque AB; Borges GF; Franchi R; Rim PH; Medina FM; Costa FF; Melo MB; de Vasconcellos JP
    Exp Biol Med (Maywood); 2021 Nov; 246(21):2290-2296. PubMed ID: 34233521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.
    Seddon JM; Reynolds R; Maller J; Fagerness JA; Daly MJ; Rosner B
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2044-53. PubMed ID: 19117936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.
    Hughes AE; Orr N; Esfandiary H; Diaz-Torres M; Goodship T; Chakravarthy U
    Nat Genet; 2006 Oct; 38(10):1173-7. PubMed ID: 16998489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
    Loane E; Nolan JM; McKay GJ; Beatty S
    Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.